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Portalhypertension,especiallywhenitiscausedbyextrahepaticportalveinthrombosis,iscommonlyfollowedbythedevelopment
of an abnormal periportal and pericholedochal variceal network, which form a portal cavernoma. This may exert extrinsic
pressureontheadjacentbiliaryductsandgallblader,causingmorphologicabnormalities,termedportalbiliopathy,whichisusually
leading to asymptomatic cholestasis, while less frequently it can be associated with obstructive jaundice, gallstone formation, and
cholangitis. Endoscopic stone extraction can eﬀectively treat portal biliopathy when cholangitis is associated with common bile
duct stones. Portosystemic shunts are indicated in cases of disease recurrence as they can achieve regression of portal cavernoma
and usually relieve symptomatic portal biliopathy. This case describes an alternative partial portosystemic shunt that utilizes the
right ovarian vein as an autologous conduit for the surgical treatment of symptomatic portal biliopathy.
Copyright © 2009 Konstantinos Vasiliadis et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Extrahepatic portal vein thrombosis (EPVT) is a common
causeofportalhypertension(PH)andiscommonlyfollowed
by the formation of several periportal and pericholedochal
collaterals [1, 2]. The development of this variceal network
within the hepatic pedicle forms a portal cavernoma (PC)
[3], which may exert extrinsic pressure on the adjacent
biliary ducts, causing morphologic biliary abnormalities,
termed portal biliopathy (PB) [4]. Usually, PB is leading to
asymptomatic cholestasis, while less frequently is associated
with obstructive jaundice, gallstone formation, and cholan-
gitis [4, 5]. Endoscopic sphincterotomy and stone extraction
can eﬀectively treat PB when cholangitis is associated with
common bile duct stones while total portosystemic shunt
surgery is indicated when biliary obstruction is recurrent
and/or progressive [6, 7]. Portal biliopathy poses a chal-
lenging therapeutic problem, as the presence of both PC
and PH represent a signiﬁcant obstacle to the surgical
treatment of biliary obstruction. This case describes an
alternativeportosystemicshuntthatutilizestherightovarian
vein as an autologous conduit for the surgical treatment of
recurrent symptomatic portal biliopathy. To our knowledge,
this is the ﬁrst case reported in the medical literature
of portal vein thrombosis associated with elevated factor
VIII levels, which was complicated by symptomatic portal
biliopathy and was treated with an alternative portosystemic
shunt.
2.CaseReport
A 39-year-old female patient was referred in April 2007
to the Surgical Department of the University Hospital of
Heidelberg with a 3-year history of relapsing episodes of




extensive diagnostic thrombophilic evaluation for idiopathic2 HPB Surgery
extrahepatic portal vein thrombosis complicated with PH.
Extrahepatic PH was manifested with ascites, splenomegaly,
and bleeding episodes from grade II oesophageal varices.
The latter was treated by endoscopic sclerotherapy . At the
time of initial presentation spiral computed tomography
(CT) scan of the abdomen depicted a superior mesenteric
and portal vein thrombosis in addition to cavernomatous
transformation of the portal vein. Her family history was
negative for thromboembolic events while she denied the
use of oral contraceptive at the time of presentation.
After diagnosis she was started on phenprocoumon for
anticoagulation, which however discontinued because of
episodesofvaricealbleeding.Abeta-blockerandnitratewere
also administered for the treatment of portal hypertension.
Six months following the initial presentation the patient
started to complain of recurrent episodes of right upper
quadrant pain, typically of biliary origin. Laboratory values
showed a cholestatic pattern while abdominal ultrasound
demonstrated a normal echogenicity of the liver as well
as dilatation and irregularity of the common bile duct
(CBD), which appeared surrounded by multiple tortuous
collaterals in the region of the porta hepatis. The gall-
bladder appeared contracted and had multiple overlying
collaterals, and contained stones and debris. Endoscopic
retrograde cholangiopancreatography (ERCP) established
the diagnosis of portal biliopathy by revealing irregular
outline of the CBD in addition to several ﬂat impressions,
presumably caused by venous collaterals (Figure 1). These
ﬁndings were consistent with grade I portal biliopathy [2].
After papillotomy, complete bile duct stone clearance was
accomplished, followed by the insertion of an Amsterdam
type biliary endoprosthesis. Laboratory values of cholestatic
pattern improved in the immediate post-ERCP period. She
was treated with ursodesoxicholic acid and was scheduled
for a repeat ERCP session after a three-month interval.
However, two months later a relapsing episode of obstructive
jaundice and cholangitis ensued necessitating a repeat ERCP
session and stent change. During the last 3-years, multiple
ERCP sessions and stent changes were required, because
of relapsing attacks of cholangitis, without, however, a
deﬁnitive improvement. The patient was therefore referred
for evaluation to our department and after a thorough con-
sultation with the patient, the gastroenterologist and haema-
tologist a decision was made for an open cholecystectomy
and a portosystemic shunt. Preoperative magnetic resonance
imaging (MRI) of the abdomen showed persistence of supe-
rior mesenteric and portal vein thrombosis, and cavernous
transformation of the portal vein (Figure 2). Laparotomy
was performed through an L-incision. After entering the
peritonealcavitylarge,dilated,tortouscollateralswerefound
at the porta hepatis and around the CBD, crossing over
the hepatoduodenal ligament and the gallbladder. Multiple
inﬂammatory adhesions between the omentum and the
contracted gallbladder were also present. Cholecystectomy
was performed in a fundus-ﬁrst approach. After careful
dissection, and ligation of several tortous collaterals, the
vessels and cystic duct in Calot’s triangle were identiﬁed
and ligated. Following cholecystectomy, it was decided to
proceed with a portosystemic shunt. The distal portal vein
(PV) was carefully isolated by minimal dissection avoiding
the cavernoma in the liver hilum. The anterior portion of
the adjacent inferior vena cava (IVC) was also dissected
at the site chosen for the portocaval anastomosis. It was
at this stage decided to perform a PV and IVC pressure
measurement. The PV pressure was measured 30mmHg,
while IVC pressure 9mmHg. However, the creation of a
tension free side-to-side portocaval shunt proved technically
not possible because of approximation diﬃculty, owing to
the long vertical distance between the distal PV and IVC.
In a search for potential H-shunt options, and considering
the fact that patient’s thrombophilia would made the use
of a synthetic graft prone to thrombosis, a large 6mm in
diameter right ovarian vein draining into the IVC just caudal
to the right renal vein appeared to be of adequate size and
quality to be utilized as an autologous conduit, to perform a
portosystemic shunt (Figure 3). Indeed, approximately 8cm
of its length was mobilized and the right ovarian vein was
divided and ligated distally. After systemic anticoagulation
with heparin, the proximal end of the ovarian vein was
anastomosed end-to-side to the distal portal vein with a
continuous 6-0 PDS suture (Figures 4(a) and 4(b)). After
clamp removal, Doppler conﬁrmed excellent ﬂow, while
the pressure gradient between PV and IVC was once again
measured conﬁrming a reduction of at least 57% (the
PV pressure was measured 20mmHg, while IVC pressure
8mmHg). The right ovarian vein had a smooth curve
under the duodenum when the retractors were relaxed.
This technique allowed bypassing the thrombosed portion
of the portal vein by avoiding dissection of the cavernoma
in the liver hilum and related risk of massive hemorrhage.
The patient had an uncomplicated postoperative course
a n da na b d o m i n a lC Ts c a n( Figure 5)p e r f o r m e dp r i o rt o
discharge home conﬁrmed patency of the shunt, despite
diﬃculty visualizing the shunt by US examination. Low-
molecular weight heparin was administered subcutaneously
for three weeks, as she was scheduled to undergo a
new ERCP session and stent removal by the end of this
period.FollowingERCPandstentremoval,phenprocoumon
was administered for anticoagulation. The patient did not
developed encephalopathy while she has had no further
episodes of bleeding, jaundice, abdominal pain, or recur-
rent fever, and no therapeutic intervention was required
during a 19-month follow-up period (Table 1), although
morphologic biliary abnormalities seen at US tended to
persist.
3. Discussion
Underlying speciﬁc coagulation defects are increasingly
recognizedasprecipitatingfactorsofextrahepaticportalvein
thrombosis (EPVT) [8]. In fact, in many patients with EPVT,
multiple thrombophilic conditions are present and these
may play an important role in the pathogenesis of EPVT
[8]. However, elevated concentration of factor VIII has been
rarely associated with this disorder [8–13].
Regardless of speciﬁc causative mechanisms, EPVT
comes usually to clinical attention because of complicationsHPB Surgery 3
Table 1: Clinical course of the patient.
Date Pathological condition Management
10.2003
Idiopathic extrahepatic portal and superior mesenteric
vein thrombosis, because of elevated factor VIII level,
complicated with portal hypertension
Administration of phenprocoumon for anticoagulation
(discontinued because of episodes of variceal bleeding),
and beta-blocker and nitrate for portal hypertension
12.2003 Bleeding episodes from grade II oesophageal varices Endoscopic sclerotherapy
04.2004 Grade I portal biliopathy
Endoscopic complete bile duct stone clearance and
insertion of a biliary endoprosthesis, administration of
ursodesoxicholic acid
06.2004–02.2007 Numerous relapsing episodes of symptomatic portal
biliopathy
Multiple ERCP sessions and stent changes without a
deﬁnitive improvement
04.2007 Symptomatic portal biliopathy- decision making for
surgical management
Open cholecystectomy and an alternative portosystemic
shunt (right porto-ovarian H-shunt)
05.2007–present
None. The patient did not developed encephalopathy
while she has had no further episodes of bleeding,
jaundice, abdominal pain, or recurrent fever
No therapeutic intervention was required
Figure 1: Tight and irregular stenosis of the common bile duct
(white arrow) with upstream dilatation of its narrowed segment,
in addition to multiple ﬂat impressions. One solitary stone was also
present (black arrow).
of PH [4, 6, 14]. Portal hypertension leads to the devel-
opment of numerous venous collaterals that decompress
into the systemic circulation. Bleeding from esophagogastric
varices, which are commonly formed in the setting of
EPVT, represent the most frequent manifestation of PH [15].
Furthermore, extensive collateral venous circulation can also
develop from the epicholedochal venous plexus of Saint [16]
and paracholedochal venous plexus of Petren [17] at the
porta hepatis and bile ducts forming a portal cavernoma
(PC) [4]. This may exert extrinsic pressure on biliary ducts,
causing morphologic biliary abnormalities [5].
Portal biliopathy (PB), which is a recent terminology,
describes these abnormal changes that include irregular
strictures and dilatation of both extra and intrahepatic bile
ducts, segmental dilated segments with a beaded appear-
ance, ectasia and “pruning” of the intrahepatic bile ducts
Figure 2: Coronal MRI T2 weighted image showing a solid tumor-
like mass at the hepatic hilum (portal cavernoma), (white arrow) in
addition to hyposignal (thrombus) at the level of mesentiricoportal
conﬂuence (black arrow).
and varices of the gallbladder [18]. In this case patient’s
gallbladder had multiple overlying collaterals, while the CBD
appeared dilated with an hourglass appearance upstream to
PC.
Khuroo et al. [19] have speculated that the abnormal
CBD changes that develop in patients with PB could form
because of vascular injuries at the time of portal vein
thrombosis. They claimed that an extension of the throm-
botic process might cause ischemic necrosis of bile ducts
and subsequent stricture formation, caliber irregularities of
biliary ducts and cholangiectases. On the other hand Webb
and Sherlock [20] postulated that mechanical compression
by engorged venous collaterals could be responsible for the
development of symptomatic PB. Nevertheless, it should be
noted that these and other diﬀerent pathogenetic hypotheses
are not mutually exclusive, and that each of various theories
explain in part biliary and/or gallblader involvement in
patients with PB [2]. In this case the presence of biliary4 HPB Surgery
IVC
Right ovarian vein
Figure 3: Operative photograph. The right ovarian vein, 6mm in
diameter draining into the IVC (inferior vena cava) just caudal to
the right renal vein.
abnormalities combined with biliary colic, in the absence of
biliary symptoms before EPVT and cavernous transforma-
tion of the portal vein, is indicative of a potential role for
biliary stasis.
Portal biliopathy secondary to PC although quite com-
mon among patients with EPVT remains, however, a very
rare and usually asymptomatic entity [18]. The majority of
patients present asymptomatic cholestasis and demonstrate
the characteristic changes of PB only on ERCP and/or MRCP
[19, 21]. Several studies suggest that the prevalence of PB
secondary to PC can range from 80% to 93% [5, 19, 21].
Rarely,biliarychangesinpatientswithPBbecomesigniﬁcant
togiverisetoovertobstructivejaundiceandcontributetothe
development of cholelithiasis and choledocholithiasis [18].
Upper quadrant pain typically of biliary origin, recurrent
fever with chills and jaundice alone or in combination
suggest the possibility of symptomatic PB. In this case the
patient had neither biliary symptoms nor gallstone disease
at onset however; during follow-up she developed recurrent
attacks of cholecystitis and cholangitis.
At present the management of PB is selective and is
directed only to symptomatic patients [7, 18]. Asymp-
tomatic patients do not require any treatment, especially
if the liver function tests are normal. Choledocholithiasis,
a known complication of PB in patients with EPVT, can
be managed by endoscopic sphincterotomy (ES) and stone
extraction [2]. Notwithstanding this, biliary changes often
remainingunrelievedandchancesofrecurrentstonesremain
high. Thereby, the presence of strictures and/or signiﬁcant
abnormalities of CBD often necessitate the insertion of a
biliary endoprosthesis [6]. This endoprosthesis often needs
to be changed and sometimes, multiple ERCP sessions are
required to keep the lumen patent, as happened in the
present case. In regards to the eﬀectiveness of ERCP and
ES in the treatment of symptomatic PB it should be noted
that a limited number of cases have documented successful
treatment of symptomatic PB with only the insertion of a
plastic stent [22].
In the presence of recurrent and/or progressive PB
not amenable to endoscopic therapy, portosystemic shunt
surgerydecompressingportalcirculationandcausingregres-
sion of varices is indicated to relieve biliary stasis and











Figure 4: Operative photograph. Completion of the end-to-side
right portoovarian anastomosis with a continuous 6-0 PDS suture,
before (a) and after (b) clamp removal (PV: portal vein, IVC:
inferior vena cava).
Figure 5: Postoperative coronal abdominal contrast enhanced CT
scan shows opaciﬁcation of the mesogonadal shunt (white arrow)
conﬁrming its patency.HPB Surgery 5
management of these patients poses a challenging dilemma,
as the presence of both PC and PH represent a signiﬁcant
obstacle to surgery. Indeed, dissection of the hepatic pedicle
in the presence of PC can lead to life threatening hemorrhage
[4,7,18]. Furthermore, the presentation of PBcan be similar
to cholangiocarcinoma [23] or sclerosing cholangitis [21]
raising serious diagnostic issues that could lead to major
errors in the management of this entity.
A variety of procedures have been used to treat
symptomatic PB, however the optimal therapeutic strategy
remains controversial. The ﬁrst case of portosystemic shunt
for symptomatic PB was reported by Choudhuri et al. [24].
They treated successfully symptomatic PB by performing
a splenectomy and proximal splenorenal shunt. To date,
30 patients have been treated for symptomatic PB with
a portosystemic anastomosis [4, 7, 24–28]. A mesocaval
shunt with jugular vein interposition was the most fre-
quent approach in pediatric patients while splenectomy and
proximal splenorenal anastomosis was the most frequently
performed operation in adults. In the most recently reported
study, Vibert et al. [7] treated successfully 10 patients with
symptomatic PB by performing a splenorenal anastomosis
with internal jugular interposition graft via a retroperitoneal
approach.Intheabove-mentionedstudytheauthorsclaimed
that the principal beneﬁt of this approach was that the
formation of peritoneal adhesions that could complicate
a potentially necessary subsequent biliodigestive bypass is
avoided.
In the present case the surgical strategy aimed primarily
to decompress PC after performing an open cholecystectomy
with the intent to relieve symptoms of biliary colic and
prevent gallstone disease related complications. A mesocaval
shunt was not an option because of superior mesenteric
vein thrombosis, while a direct side-to-side portacaval
shunt proved not possible because of complicated anatomy.
Thereby, the right ovarian vein was successfully used as
an in situ conduit to create an H-type portosystemic
shunt. This alternative procedure created eﬀectively a partial
shunt oﬀering additional shunt options in a patient with
complicated anatomy and serious co-morbid conditions,
while in parallel; it proved to be equivalent in function
to the classic H-type portacaval shunt. Furthermore, this
right portoovarian shunt was only partially diverting it
using an autologous tissue, and was relatively easy to
perform requiring only a single anastomosis with minimal
dissection. In conclusion, this report describes the usefulness
of an alternative type of portosystemic shunt that may be
considered in patients with symptomatic portal biliopathy
having the appropriate anatomy and limited shunt options
because of serious comorbid conditions.
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